IrsiCaixa news release
For the first time, and thanks to spatial imaging techniques, a clinical trial shows how antiretroviral drugs are distributed within human lymph nodes and claims that they reach areas where HIV-infected cells persist.
The results of the clinical trial, published in Nature Communications, show that the combination of dolutegravir and lamivudine not only reaches the lymph nodes and is efficiently distributed in areas where virus-infected cells predominate, but also manages to rapidly reduce the HIV reservoir during the first year of treatment.
Read the full news release here.
Source : IrsiCaixa
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.